| Reference |
|---|
Yun J, Hong Y, Hong M, Kim G, Lee J, Woo R, et al. Anti-inflammatory effects of neuregulin-1 in HaCaT keratinocytes and atopic dermatitis-like mice stimulated with Der p 38. Cytokine. 2024;174:156439 pubmed publisher
|
Podder A, Mohamed M, Tseropoulos G, Nasiri B, Andreadis S. Engineering Nanofiber Scaffolds with Biomimetic Cues for Differentiation of Skin-Derived Neural Crest-like Stem Cells to Schwann Cells. Int J Mol Sci. 2022;23: pubmed publisher
|
Yang H, Pan W, Xiao W, Yang M, Xu J, Li J, et al. Antipsychotic drugs increase Neuregulin1β1 serum levels in first-episode drug-naïve patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptoms. BMC Psychiatry. 2022;22:217 pubmed publisher
|
Shin D, Kim S, Choi M, Bae Y, Han C, Choi B, et al. Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1. Oncogene. 2022;41:280-292 pubmed publisher
|
Mouton Liger F, Dumurgier J, Cognat E, Hourregue C, Zetterberg H, Vanderstichele H, et al. CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer's disease. Alzheimers Res Ther. 2020;12:88 pubmed publisher
|
Wang S, Li R, Ng T, Luthria G, Oudin M, Prytyskach M, et al. Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy. Sci Adv. 2020;6:eaaz8521 pubmed publisher
|
Szułdrzyński K, Jankowski M, Potaczek D, Undas A. Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein. Dis Markers. 2020;2020:7190828 pubmed publisher
|
Ryu S, Lee J, Bae C, Moon C, Cho K. Therapeutic efficacy of neuregulin 1-expressing human adipose-derived mesenchymal stem cells for ischemic stroke. PLoS ONE. 2019;14:e0222587 pubmed publisher
|
Li C, Tao H, Yang X, Zhang X, Liu Y, Tang Y, et al. Assessment of a combination of Serum Proteins as potential biomarkers to clinically predict Schizophrenia. Int J Med Sci. 2018;15:900-906 pubmed publisher
|
Schwartz N, Pellach M, Glick Y, Gil R, Levy G, Avrahami D, et al. Neuregulin 1 discovered as a cleavage target for the HCV NS3/4A protease by a microfluidic membrane protein array. N Biotechnol. 2018;45:113-122 pubmed publisher
|
Miura Y, Sukawa Y, Hironaka S, Mori M, Nishikawa K, Tokunaga S, et al. Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G). Gastric Cancer. 2018;21:84-95 pubmed publisher
|
Buta C, Benabou E, Lequoy M, Régnault H, Wendum D, Meratbene F, et al. Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin. J Exp Clin Cancer Res. 2016;35:126 pubmed publisher
|
Mukai H, Saeki T, Aogi K, Naito Y, Matsubara N, Shigekawa T, et al. Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2-overexpressing metastatic breast cancer. Cancer Sci. 2016;107:1465-1470 pubmed publisher
|
Gijsen M, King P, Perera T, Parker P, Harris A, Larijani B, et al. HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer. PLoS Biol. 2010;8:e1000563 pubmed publisher
|
Hickinson D, Marshall G, Beran G, Varella Garcia M, Mills E, South M, et al. Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib. Clin Transl Sci. 2009;2:183-92 pubmed publisher
|
Calvo M, Zhu N, Tsantoulas C, Ma Z, Grist J, Loeb J, et al. Neuregulin-ErbB signaling promotes microglial proliferation and chemotaxis contributing to microgliosis and pain after peripheral nerve injury. J Neurosci. 2010;30:5437-50 pubmed publisher
|
Hoffmann I, Bueter W, Zscheppang K, Brinkhaus M, Liese A, Riemke S, et al. Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns. Brain Behav Immun. 2010;24:784-91 pubmed publisher
|
Xu G, Watanabe T, Iso Y, Koba S, Sakai T, Nagashima M, et al. Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis. Circ Res. 2009;105:500-10 pubmed publisher
|
Ky B, Kimmel S, Safa R, Putt M, Sweitzer N, Fang J, et al. Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure. Circulation. 2009;120:310-7 pubmed publisher
|
Zhou B, Peyton M, He B, Liu C, Girard L, Caudler E, et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell. 2006;10:39-50 pubmed
|